During the past decade, Tucson Medical Center conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 7 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 3 clinical trials were completed. i.e. 15% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tucson Medical Center" #1 sponsor was "Boston Scientific Corporation" with 5 trials, followed by "Instituto Bioclon S.A. de C.V." with 4 trials sponsored, "Obstetrix Medical Group" with 4 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored and "Edwards Lifesciences" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tucson Medical Center" #1 collaborator was "University of Arizona" with 4 trials as a collaborator, "Universidad Nacional Autonoma de Mexico" with 3 trials as a collaborator, "Obstetrix Medical Group" with 2 trials as a collaborator, "Acelis Connected Health" with 1 trials as a collaborator and "Avania" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Tucson Medical Center" are "Stroke" (3 trials), "Aortic Valve Stenosis" (2 trials), "Cervical Ripening" (2 trials), "Coronary Artery Disease" (2 trials) and "Intra-amniotic Infection" (2 trials). Many other conditions were trialed in "Tucson Medical Center" in a lesser frequency.

Most popular intervention types in "Tucson Medical Center" are "Device" (21 trials), "Drug" (12 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Inclisiran" (2 trials), "0.9% NaCl" (1 trials), "17-alpha-hydroxy-progesterone caproate, Makena®" (1 trials) and "17-alpha-hydroxyprogesterone caproate injectable" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tucson Medical Center" are 31 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Tucson Medical Center". undefined are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Tucson Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tucson Medical Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 20 trials that are defined as “Not Applicable".

Tucson Medical Center has several departments that took part in Clinical trials: "Desert Sun Gastroenterology" - 5 trials